Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jonas Graversen"'
Autor:
Frederik Larsen, Mike Terkelsen, Sofie Bendixen, Daniel Hansen, Charlotte Wernberg, Mette Lauridsen, Tina Di Caterino, Fabio Avolio, Majken Siersbæk, Vineesh Indira Chandran, Jonas Graversen, Aleksander Krag, Lars Groentved, Kim Ravnskjaer
Publikováno v:
Journal of Hepatology. 77:S423
Autor:
Charlotte Wernberg, Vineesh Indira Chandran, Mette Lauridsen, Frederik Larsen, Maria Kløjgaard Skytthe, Camilla Dalby Hansen, Majken Siersbæk, Tina Di Caterino, Sönke Detlefsen, Yaseelan Palarasah, Kim Ravnskjaer, Lars Groentved, Søren Kragh Moestrup, Maja Thiele, Jonas Graversen, Aleksander Krag
Publikováno v:
Journal of Hepatology. 77:S434
Autor:
Geert Bultynck, Laurence Lecordier, Ana Raquel Ramos, Stijn Deborggraeve, Marjorie Vermeersch, Patricia Tebabi, Elena Levtchenko, Christophe Legendre, Søren K. Moestrup, Pepe Ekulu Mfutu, Tomas Luyten, Sophie Uzureau, Christophe Erneux, Marc Dieu, Dorle Hennig, David Perez-Morga, Pierrick Uzureau, Rita Rm La Rovere, Etienne Pays, Bart Cuypers, Jonas Graversen, Marion Rabant, Fanny Oliveira Arcolino, Fabrice Homblé
Publikováno v:
Uzureau, S, Lecordier, L, Uzureau, P, Hennig, D, Graversen, J H, Homblé, F, Mfutu, P E, Oliveira Arcolino, F, Ramos, A R, La Rovere, R M, Luyten, T, Vermeersch, M, Tebabi, P, Dieu, M, Cuypers, B, Deborggraeve, S, Rabant, M, Legendre, C, Moestrup, S K, Levtchenko, E, Bultynck, G, Erneux, C, Pérez-Morga, D & Pays, E 2020, ' APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin ', Cell Reports, vol. 30, no. 11, pp. 3821-3836 . https://doi.org/10.1016/j.celrep.2020.02.064
Cell Reports
Uzureau, S, Lecordier, L, Uzureau, P, Hennig, D, Graversen, J H, Homblé, F, Mfutu, P E, Oliveira Arcolino, F, Ramos, A R, La Rovere, R M, Luyten, T, Vermeersch, M, Tebabi, P, Dieu, M, Cuypers, B, Deborggraeve, S, Rabant, M, Legendre, C, Moestrup, S K, Levtchenko, E, Bultynck, G, Erneux, C, Pérez-Morga, D & Pays, E 2020, ' APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin ', Cell Reports, vol. 30, no. 11, pp. 3821-3836.e13 . https://doi.org/10.1016/j.celrep.2020.02.064
Cell reports, 30 (11
Cell Reports, Vol 30, Iss 11, Pp 3821-3836.e13 (2020)
Cell reports
Cell Reports
Uzureau, S, Lecordier, L, Uzureau, P, Hennig, D, Graversen, J H, Homblé, F, Mfutu, P E, Oliveira Arcolino, F, Ramos, A R, La Rovere, R M, Luyten, T, Vermeersch, M, Tebabi, P, Dieu, M, Cuypers, B, Deborggraeve, S, Rabant, M, Legendre, C, Moestrup, S K, Levtchenko, E, Bultynck, G, Erneux, C, Pérez-Morga, D & Pays, E 2020, ' APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin ', Cell Reports, vol. 30, no. 11, pp. 3821-3836.e13 . https://doi.org/10.1016/j.celrep.2020.02.064
Cell reports, 30 (11
Cell Reports, Vol 30, Iss 11, Pp 3821-3836.e13 (2020)
Cell reports
Summary The C-terminal variants G1 and G2 of apolipoprotein L1 (APOL1) confer human resistance to the sleeping sickness parasite Trypanosoma rhodesiense, but they also increase the risk of kidney disease. APOL1 and APOL3 are death-promoting proteins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb521d30392cbb871aac6dc615d4c993
https://findresearcher.sdu.dk:8443/ws/files/168815992/Open_Access_Version.pdf
https://findresearcher.sdu.dk:8443/ws/files/168815992/Open_Access_Version.pdf